Colorectal cancer liver metastases (CRLM) remain a major therapeutic challenge, shaped by marked biological heterogeneity and unpredictable clinical outcomes. While classical Clinical Risk Scores (CRS) continue to inform surgical decision making, their static ... ...

请注册登录后继续浏览